The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Cell Viability Assays Global Market Report 2024, the cell viability assays market is expected to show significant growth in the forecast period.

The cell viability assays market has experienced significant growth, increasing from $1.41 billion in 2023 to $1.56 billion in 2024 at a CAGR of 10.5%. This growth is projected to continue, reaching $2.34 billion by 2028 with a CAGR of 10.6%.

Key Drivers of Growth

• Investment in Cancer Research:
  • Increased funding and research initiatives targeting cancer have propelled the demand for cell viability assays.
• Pharmaceutical R&D Expenditure:
  • Rising investment in pharmaceutical research and development has driven the market forward.
• Biotechnology Sector Expansion:
  • Growth in the biotechnology sector has significantly contributed to the market’s expansion.
• Advancements in Cell Culture Techniques:
  • Improvements in cell culture techniques have enhanced the accuracy and efficiency of cell viability assays.
• Stem Cell Research Demand:
  • Increasing interest in stem cell research has led to a higher demand for cell viability assays.
• Need for Toxicity Testing:
  • The necessity for rigorous toxicity testing in drug development has fueled market growth.
• Real-Time Cell Analysis Systems:
  • The rise in utilization of real-time cell analysis systems has optimized the efficiency of cell viability assays.
• Contract Research Organizations (CROs):
  • The growing number of CROs has expanded the availability and accessibility of cell viability assays.

View More On The Cell Viability Assays Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Future Growth Prospects
The forecast period is expected to see rapid growth due to several factors:

• Personalized Medicine:
  • Increasing demand for personalized medicine is driving the market.
• Government Funding for Cell-Based Research:
  • Enhanced government funding is supporting cell-based research initiatives.
• Precision Medicine Focus:
  • A greater emphasis on precision medicine is boosting market growth.
• Stem Cell Research and Applications:
  • Continued advancements and applications in stem cell research are propelling the market forward.
• Automated Cell Viability Analyzers:
  • Increasing availability of automated analyzers is improving assay efficiency.
• Infectious Disease Incidence:
  • A rise in the incidence of infectious diseases is elevating the demand for cell viability assays.
• Improved Assay Accuracy and Sensitivity:
  • Focus on enhancing assay accuracy and sensitivity is driving market growth.
• Awareness of Assay Benefits:
  • Growing awareness about the advantages of cell viability assays is boosting market adoption.
• Organ on a Chip Technologies:
  • Development of organ on a chip technologies is expected to drive the market.
• Regenerative Medicine Demand:
  • Increasing demand for regenerative medicine is contributing to market growth.

Emerging Trends

• High Throughput Screening Methods:
  • Advances in high throughput screening methods are revolutionizing the market.
• AI and Machine Learning:
  • Implementation of AI and machine learning algorithms is enhancing assay accuracy.
• Real-Time Monitoring Systems:
  • Development of real-time monitoring systems is improving cell viability assays.
• Automated Liquid Handling Systems:
  • Adoption of automated liquid handling systems is increasing assay efficiency.
• Multiplex Assays:
  • Development of multiplex assays allows simultaneous measurement of cell viability.
• Eco-Friendly Reagents:
  • Adoption of more sustainable and eco-friendly reagents is a key trend.
• User-Friendly Assay Kits:
  • Development of user-friendly assay kits is making cell viability assays more accessible.
• Electrochemical Assays:
  • Advancements in electrochemical assays are enhancing the market.
• Scalable Cell Viability Assays:
  • Implementation of scalable assays is addressing growing demand.
• Compatibility with Primary Cells and Stem Cells:
  • Development of assays compatible with primary and stem cells is driving innovation.

Role of Cell-Based Therapeutics
Cell-based therapeutics are driving the growth of the cell viability assays market. These treatments use living cells to repair or replace damaged tissue and treat diseases. Advances in biotechnology, investment in regenerative medicine, and improvements in cell engineering are fueling this growth. For instance, 38 trials for non-genetically modified cell therapies were initiated in Q1 2023, highlighting the increasing adoption of cell-based therapeutics.

Major Players in the Market
Key companies in the cell viability assays market include:

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Becton, Dickinson, and Company
• Agilent Technologies Inc.
• Lonza Group Ltd.
• PerkinElmer Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories Inc.

Innovative Technologies in Drug Discovery
Companies are developing innovative cell screening technologies to improve drug discovery. For example, Arralyze introduced CellShepherd in May 2024, a platform for single-cell analysis using proprietary nanowell glass arrays, enhancing real-time monitoring and analysis.

Strategic Acquisitions
BD Biosciences acquired Cytognos in February 2022 to expand its portfolio in blood cancer diagnostics and immune monitoring. This acquisition highlights the strategic moves by companies to strengthen their market position.

Market Segmentation

• By Product: Consumables, Instruments
• By Application: Basic Research, Stem Cell Research, Drug Discovery and Development, Clinical and Diagnostic Applications, Other Applications
• By End-User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Users

North America was the largest region in the market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period.

Request A Sample Of The Global Cell Viability Assays Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16014&type=smp